Over-the-counter medication · Omega-3 Supplement
omega-3 fatty acids
Also sold as Fish Oil, Lovaza. This supplement provides omega-3 fatty acids, which are important for overall health.
Data updated 2026-05-15
- 1
- InteractionFew interactions
- $8.08
- Generic price (NADAC)
omega-3 fatty acids (Fish Oil) is an over-the-counter Omega-3 Supplement. This supplement provides omega-3 fatty acids, which are important for overall health.
This medicine is an omega-3 fatty acid supplement. It contains omega-3 acids, folic acid, and vitamins to help support your health.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$8.08/unit
Generic Available
Yes (0 manufacturers)
Pricing data from NADAC (CMS), effective November 27, 2024. Compare all drug costs →
What it does
This supplement provides omega-3 fatty acids, which are important for overall health.
Common side effects
No common side effects listed.
Key warnings
No specific warnings noted. Always follow your prescriber's instructions.
The sections below are summarized in plain English from omega-3 fatty acids's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Omega-3 fatty acids are thought to work by reducing inflammation in the body. They may also help lower triglyceride levels. The added vitamins support various bodily functions.
Known Drug Interactions
7 DRUG INTERACTIONS Increased Bleeding Risk with Anticoagulants and Antiplatelet Agents: Some published studies with omega-3 fatty acids have demonstrated prolongation of bleeding time. (7) 7.1 Increased Bleeding Risk with Anticoagulants and Antiplatelet Agents Some published studies with omega-3 fatty acids have demonstrated prolongation of bleeding time.
Mechanism: Both of these medications can slow down how quickly your blood clots, which may make you bleed more easily.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What are omega-3 fatty acids?
What is folic acid?
What are phytosterols?
Can I take this with other medications?
How long should I take this supplement?
What do the markings on the capsule mean?
What if I have trouble swallowing the capsule?
Can children take this supplement?
What if I accidentally take too many capsules?
What are the other ingredients in the capsule?
Does omega-3 fatty acids interact with other medications?
What drug class is omega-3 fatty acids?
What pregnancy or breastfeeding source fields are listed for omega-3 fatty acids?
Related Medications in Omega-3 Supplement
Other drugs grouped near omega-3 fatty acids - same-class peers and common alternatives.
ascorbic acid
Vitamin C
This medicine is a Vitamin C supplement.
Compare with omega-3 fatty acids →
biotin
Vitamin B7
Dialyvite with Zinc is a prescription vitamin supplement.
Compare with omega-3 fatty acids →
calcitriol
Rocaltrol
Calcitriol is a form of vitamin D that helps your body absorb and use calcium.
Compare with omega-3 fatty acids →
calcium carbonate
Tums, Caltrate
Calcium carbonate is a medicine that can relieve heartburn and upset stomach.
Compare with omega-3 fatty acids →
cholecalciferol
Vitamin D3
PNV-DHA is a multivitamin with minerals and essential fatty acids.
Compare with omega-3 fatty acids →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for omega-3 fatty acids
The FDA label for omega-3 fatty acids (sold under brand names such as Fish Oil, Lovaza) classifies it as an over-the-counter product in the Omega-3 Supplement class. This supplement provides omega-3 fatty acids, which are important for overall health. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $8.08.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: February 13, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages